Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor (rhGM-CSF) and Autologous Melanoma Vaccine Mediate Tumor Regression in Patients with Metastatic Melanoma
Authors:
- Stanley P. L. LeongSLStanley P. L. Leong
- Paula Enders-ZohrPEPaula Enders-Zohr
- Yuan-Ming ZhouYZYuan-Ming Zhou
- Susan StuntebeckSSSusan Stuntebeck
- Fahim A. HabibFHFahim A. Habib
- Robert E. AllenRARobert E. Allen
- Richard W. SagebielRSRichard W. Sagebiel
- Alan B. GlassbergAGAlan B. Glassberg
- David W. LowenbergDLDavid W. Lowenberg
- F Ann HayesFHF Ann Hayes
- 1 March 1999
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal of Immunotherapy
- Vol. 22 (2) , 166-174